AVBC vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health scores paint a concerning picture, with a Piotroski F-Score of just 1/9 indicating severe financial weakness. Despite strong year-over-year revenue growth of 28%, the company is unprofitable with negative profit and operating margins, undermining its financial stability. Valuation metrics like a Price/Book of 0.93 suggest the market is pricing in limited confidence, while the technical trend score of 10/100 reflects strong bearish momentum. The absence of Altman Z-Score data is a red flag, but the extremely low Piotroski score alone warrants significant caution.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
AVBC vs BRK-B: Head-to-Head Comparison
This page compares Avidia Bancorp, Inc. (AVBC) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.